Signal2026-07-23
ClinicalTrials.gov

[PHASE1] A Single-Arm, Open-Label, Prospective Study Evaluating the Safety, Tolerability, and Immunogenicity of the NeoOVSV Vaccine in Patients With Ovarian Cancer After Surgery

Part of

Cancer Nanomedicine And Liquid Biopsy

Open primary sourceSee the whole picture